Jove
Visualize
Contact Us

Related Concept Videos

Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

9.3K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.3K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

5.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.8K
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

11.0K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
11.0K
Cancer Survival Analysis01:21

Cancer Survival Analysis

620
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
620
Mouse Models of Cancer Study02:43

Mouse Models of Cancer Study

6.3K
Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
6.3K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

6.8K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Shrinky Dinks-Based Bionic Meta-Microneedles for Advancing Wound Healing.

ACS applied materials & interfaces·2026
Same author

Strain-localized luminescent e-skin for high-resolution pressure mapping and visual force feedback.

Nature communications·2026
Same author

Wash-Free Digital Detection of Tumor Extracellular Vesicles via Plasmonic Droplet Microfluidics.

ACS sensors·2026
Same author

Integrated single-cell transcriptomic atlas of human gastric and colorectal tissues across diverse phenotypes.

Scientific data·2026
Same author

Brain Extracellular Matrix-Based Electronic Brain Biochip.

ACS nano·2026
Same author

Advances in machine learning-enhanced microfluidic cell sorting.

Science advances·2025
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jan 6, 2026

Cancer-Associated Fibroblasts from Mouse Mammary Tumors as Tools for Molecular and Computational Studies
09:01

Cancer-Associated Fibroblasts from Mouse Mammary Tumors as Tools for Molecular and Computational Studies

Published on: July 3, 2025

787

Compendiums of cancer transcriptomes for machine learning applications.

Su Bin Lim1,2, Swee Jin Tan3, Wan-Teck Lim4,5,6

  • 1NUS Graduate School for Integrative Sciences & Engineering, National University of Singapore, Singapore, Singapore.

Scientific Data
|October 10, 2019
PubMed
Summary

We created a unified dataset of 8,386 cancer samples from 95 microarray studies. This merged microarray dataset (MMD) enables accurate cross-dataset analysis and biomarker discovery for improved cancer diagnostics and immune landscape understanding.

More Related Videos

Development of Compendium for Esophageal Squamous Cell Carcinoma
03:36

Development of Compendium for Esophageal Squamous Cell Carcinoma

Published on: April 12, 2024

727
Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases
07:41

Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases

Published on: May 17, 2019

9.4K

Related Experiment Videos

Last Updated: Jan 6, 2026

Cancer-Associated Fibroblasts from Mouse Mammary Tumors as Tools for Molecular and Computational Studies
09:01

Cancer-Associated Fibroblasts from Mouse Mammary Tumors as Tools for Molecular and Computational Studies

Published on: July 3, 2025

787
Development of Compendium for Esophageal Squamous Cell Carcinoma
03:36

Development of Compendium for Esophageal Squamous Cell Carcinoma

Published on: April 12, 2024

727
Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases
07:41

Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases

Published on: May 17, 2019

9.4K

Area of Science:

  • Bioinformatics
  • Genomics
  • Cancer Research

Background:

  • Massive transcriptome profiles from microarrays exist but are difficult to analyze across diverse platforms and preprocessing methods.
  • Cross-dataset analysis is time-consuming and requires significant bioinformatics expertise.
  • A unified data source is needed to facilitate data reuse for biomarker discovery and clinical strategy validation.

Purpose of the Study:

  • To create a merged microarray-acquired dataset (MMD) integrating data across 11 major cancer types.
  • To demonstrate the utility of MMD for machine learning-based diagnostic model development and validation.
  • To explore the immune landscape of various carcinomas using machine learning optimized MMD.

Main Methods:

  • Curation of 8,386 patient-derived tumor and tumor-free samples from 95 Gene Expression Omnibus (GEO) datasets.
  • Development and application of machine learning algorithms for diagnostic model training.
  • Validation of models trained on MMD using RNA-sequencing (RNA-seq) data from The Cancer Genome Atlas (TCGA).

Main Results:

  • Diagnostic models trained on MMD achieved high classification accuracy when applied to TCGA RNA-seq data.
  • Machine learning optimization of MMD revealed critical insights into the immune landscape across various carcinomas.
  • The unified MMD serves as a valuable resource for developing and refining machine learning algorithms for cancer genomics.

Conclusions:

  • The MMD provides a unified, accessible resource for large-scale transcriptome analysis in cancer research.
  • This integrated dataset facilitates biomarker discovery and the development of robust diagnostic models.
  • The MMD aids in understanding the tumor immune microenvironment, crucial for clinical interventions and disease management.